Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > So no answer on my aristotle testing question
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(445)
•••
Comment by Liked2Thinkon Nov 16, 2021 9:16am
88 Views
Post# 34130980

RE:So no answer on my aristotle testing question

RE:So no answer on my aristotle testing questionhence why they didnt split it out on the financials.  They think the investors are stupid.

They said aristotle tests were being done in Q3
They said covid testing would return to Q1 levels

Either covid testing went even lower than Q2 or they did 0 Aristotle tests.

Oh but the backlog!  Gotta throw gasoline on that fire.

Tripp did do some smoother talking about the PP.  He made it sound like they have so much demand from "institutional investors" that they will do a PP not because they need cash but because its good to have the "big guys" invovled.  What a giant load of garbage.  If anyone of you buys that nonsense then you deserve it when this tanks this morning.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities